Drug-drug
interaction
between
prescription
and
medication
statement
{
"resourceType": "DetectedIssue",
"id": "ddi",
"text": {
"status": "generated",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n <p><b>Severity: High</b> - Risk of internal bleeding</p>\n <p>Those who take acetaminophen along with the widely used blood-thinning drug warfarin may face the risk of serious internal bleeding. People on warfarin who take acetaminophen for at least seven days in a row should be closely watched for bleeding.</p>\n <ul>\n <li><a href=\"MedicationStatement/tylenol\">500 mg Acetaminophen tablet 1/day, PRN since 2010</a></li>\n <li><a href=\"MedicationRequest/warfarin\">Warfarin 1 MG TAB prescribed Jan. 5, 2014</a></li>\n </ul>\n <p>Mitigation: Jan 5, 2014 by Dr. Adam Careful: </p>\n <p>Asked patient to discontinue regular use of Tylenol and to consult with clinician if they need to resume to allow appropriate INR monitoring</p>\n </div>"
"resourceType" : "DetectedIssue",
"id" : "ddi",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n <p><b>Severity: High</b> - Risk of internal bleeding</p>\n <p>Those who take acetaminophen along with the widely used blood-thinning drug warfarin may face the risk of serious internal bleeding. People on warfarin who take acetaminophen for at least seven days in a row should be closely watched for bleeding.</p>\n <ul>\n <li><a href=\"MedicationUsage/tylenol\">500 mg Acetaminophen tablet 1/day, PRN since 2010</a></li>\n <li><a href=\"MedicationRequest/warfarin\">Warfarin 1 MG TAB prescribed Jan. 5, 2014</a></li>\n </ul>\n <p>Mitigation: Jan 5, 2014 by Dr. Adam Careful: </p>\n <p>Asked patient to discontinue regular use of Tylenol and to consult with clinician if they need to resume to allow appropriate INR monitoring</p>\n </div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ActCode",
"code": "DRG",
"display": "Drug Interaction Alert"
}
]
"status" : "final",
"category" : [{
"coding" : [{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ActCode",
"code" : "DRG",
"display" : "Drug Interaction Alert"
}]
}],
"code" : {
"coding" : [{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ActCode",
"code" : "DRG",
"display" : "Drug Interaction Alert"
}]
},
"severity": "high",
"identifiedDateTime": "2014-01-05",
"author": {
"reference": "Device/software"
"severity" : "high",
"subject" : {
"reference" : "Device/example"
},
"implicated": [
{
"reference": "MedicationStatement/example001",
"display": "500 mg Acetaminophen tablet 1/day, PRN since 2010"
"identifiedDateTime" : "2014-01-05",
"implicated" : [{
"reference" : "MedicationUsage/example001",
"display" : "500 mg Acetaminophen tablet 1/day, PRN since 2010"
},
{
"reference" : "MedicationRequest/medrx0331",
"display" : "Warfarin 1 MG TAB prescribed Jan. 15, 2015"
}],
"detail" : "Risk of internal bleeding. Those who take acetaminophen along with the widely used blood-thinning drug warfarin may face the risk of serious internal bleeding. People on warfarin who take acetaminophen for at least seven days in a row should be closely watched for bleeding.",
"mitigation" : [{
"action" : {
"coding" : [{
"system" : "http://terminology.hl7.org/CodeSystem/v3-ActCode",
"code" : "13",
"display" : "Stopped Concurrent Therapy"
}],
"text" : "Asked patient to discontinue regular use of Tylenol and to consult with clinician if they need to resume to allow appropriate INR monitoring"
},
{
"reference": "MedicationRequest/medrx0331",
"display": "Warfarin 1 MG TAB prescribed Jan. 15, 2015"
}
],
"detail": "Risk of internal bleeding. Those who take acetaminophen along with the widely used blood-thinning drug warfarin may face the risk of serious internal bleeding. People on warfarin who take acetaminophen for at least seven days in a row should be closely watched for bleeding.",
"mitigation": [
{
"action": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ActCode",
"code": "13",
"display": "Stopped Concurrent Therapy"
}
],
"text": "Asked patient to discontinue regular use of Tylenol and to consult with clinician if they need to resume to allow appropriate INR monitoring"
},
"date": "2014-01-05",
"author": {
"reference": "Practitioner/example",
"display": "Dr. Adam Careful"
}
"date" : "2014-01-05",
"author" : {
"reference" : "Practitioner/example",
"display" : "Dr. Adam Careful"
}
]
}]
}
Usage
note:
every
effort
has
been
made
to
ensure
that
the
examples
are
correct
and
useful,
but
they
are
not
a
normative
part
of
the
specification.